Norman Sharpe

Eloxx Pharmaceuticals (United States) — United States

Medicine · Health Sciences

43h-index12.9kcitations184works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heart Failure Treatment and Management(62), Cardiovascular Function and Risk Factors(57), Blood Pressure and Hypertension Studies(23), Cardiac pacing and defibrillation studies(19), Cardiac Imaging and Diagnostics(13)

Publications182 total

P251 ELX-02 pharmacokinetic profile appropriate for cystic fibrosis patient use
Journal of Cystic Fibrosis·2019Open Access
Back to the future – feasibility of recruitment and retention to patient education and telephone follow-up after hip fracture: a pilot randomized controlled trial
SHILAP Revista de lepidopterología·2015Open Access
The National Heart Foundation of New Zealand: Reviewing the Past, the Present and Future Challenges
Heart Lung and Circulation·2015
Rheumatic fever: from disease targeting to child-centredness.
PubMed·2012· 1 cited
Rheumatic fever in New Zealand: from perennial failure to successful eradication.
PubMed·2011
New Zealand's shocking diabetes rates can be reduced--9 urgently needed actions.
PubMed·2011· 2 cited
Inequities in health and the Marmot Symposia: time for a stocktake.
PubMed·2011· 5 cited
Once-daily amoxicillin for Group A Streptococcal (GAS) sore throat as the other first-line option: a clarification of the NZ sore throat guidelines.
PubMed·2011· 5 cited
Health equity: a prerequisite for social and economic progress.
PubMed·2011· 6 cited
Persistent rheumatic fever in New Zealand--a shameful indicator of child health.
PubMed·2011· 9 cited
Aspirin for primary prevention: yes or no?
Journal of Primary Health Care·2010· 11 citedOpen Access
The Wairarapa Heart Health Quality Improvement Programme
Heart Lung and Circulation·2010
Effect of carvedilol in patients with or without renal impairment after myocardial infarction: analysis of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) study.
European Heart Journal·2010· 2 cited
High Sensitivity Troponin T May Rise After Endurance Cycling: A Study of Participants in the Great Ride for Heart 2010
Heart Lung and Circulation·2010
High Sensitivity Troponin T After Endurance Cycling: A Study of Participants in the Great Ride for Heart 2010
Heart Lung and Circulation·2010
Response to Letter by Kerr and Nasco
Stroke·2009
Reducing health inequalities: a foremost priority.
PubMed·2008· 3 cited
Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand
Australian and New Zealand Journal of Public Health·2008· 49 cited
The Decline in Coronary Heart Disease Mortality Since 1980 can be Attributed Largely to Falls in Blood Pressure, Total Cholesterol and Smoking
Heart Lung and Circulation·2008
FALLS IN BLOOD PRESSURE, TOTAL CHOLESTEROL AND SMOKING HAVE CONTRIBUTED UP TO 80% OF THE DECLINE IN CORONARY HEART DISEASE MORTALITY SINCE 1980
Heart Lung and Circulation·2008
page 1 of 10Next →

Frequent Co-authors

Robert N. Doughty(16), Greg Gamble(16), Stephen MacMahon(14), Gillian Whalley(10), Mark Richards(5), Timothy G. Yandle(5), Judy Murphy(4), Warwick Bagg(4), Eric A. Espiner(3), Hamish Hart(3), Vittorio Palmieri(3), Jonathan N. Bella(3), Giovanni de Simone(3), Richard B. Devereux(3), Helen Walsh(3), Helen Oxenham(3), S. Wright(3), Richard A. Luke(3), Lindsay D. Plank(3), Keith J. Petrie(2)